The UK’s Medicines and Healthcare products Regulatory Agency has published a comprehensive updated register of licensed manufacturing sites producing both human and veterinary medicines. This regulatory database serves as an essential transparency tool for healthcare professionals, pharmacists, and pharmaceutical companies seeking to verify the licensing status of production facilities across the United Kingdom.
The register specifically tracks manufacturer specials—unlicensed medicines produced to address specific patient needs when licensed alternatives are unavailable or inappropriate—alongside veterinary manufacturer specials authorisation facilities. By maintaining this accessible database, the MHRA reinforces pharmaceutical quality assurance standards and regulatory oversight across the healthcare system.
The initiative reflects the agency’s commitment to ensuring all manufacturing sites adhere to Good Manufacturing Practice standards, strengthening public confidence in medicine safety and production quality.
Read the full article on GMJ Newsroom.
Was this article helpful?
